Earnings ·
LeMaitre Vascular reported preliminary Q2 2026 results with sales of $70.4 million, a 10% increase year-over-year, and…
LMATLemaitre Vascular Inc
LeMaitre Vascular reported preliminary Q2 2026 results with sales of $70.4 million, a 10% increase year-over-year, and diluted EPS of $0.74. The company announced a quarterly cash dividend of $0.25 per share, payable on September 3, 2026 to shareholders of record as of August 20, 2026. Management provided full-year 2026 guidance projecting sales between $274.3 million and $278.3 million (midpoint $276.3 million) and adjusted EPS between $2.84 and $2.94. LeMaitre Vascular develops, manufactures, and markets disposable and implantable vascular devices for the treatment of peripheral vascular disease.